Skip to main content

Table 4 Validation of the proposed HPLC method for determination of ebastine in pure and dosage forms

From: Validated stability indicating liquid chromatographic determination of ebastine in pharmaceuticals after pre column derivatization: Application to tablets and content uniformity testing

Preparation Repeatability, % Recovery Intermediate precision, %Recovery
Ebastine pure form Ebastine (5.0 μg/ml) Ebastine (6.0 μg/ml)
  99.95 100.95
  100.25 100.38
  100.54 99.65
  100.87 99.12
Xˉ ± SD 100.41 ± 0.39 100.03 ± 0.81
Bastab ® tablets Ebastine (0.3 μg/ml) Ebastine (4.0 μg/ml)
  99.65 99.35
  99.84 99.98
  100.58 100.87
  100.68 100.92
Xˉ ± SD 100.19 ± 0.52 100.28 ± 0.76
Evastine ® syrup Ebastine (2.0 μg/ml) Ebastine (3.0 μg/ml)
  100.14 99.32
  100.55 100.84
  100.92 100.99
  99.64 100.06
Xˉ ± SD 100.31 ± 0.55 100.31 ± 0.77